We are live on ! Find out more
OIM

Oracle Investment Management Portfolio holdings

AUM $168M
1-Year Est. Return 42.86%
This Fund
S&P 500
This Quarter Est. Return
+11.52%
1 Year Est. Return
+42.86%
3 Year Est. Return
+864.89%
5 Year Est. Return
+1,153.35%
10 Year Est. Return
+22,228.86%
AUM
$803M
AUM Growth
+$77.7M
Cap. Flow
+$364M
Cap. Flow %
45.26%
Top 10 Hldgs %
87.76%
Holding
46
New
17
Increased
9
Reduced
5
Closed
6

Top Buys

Rank Stock Value
1
VIR icon
Vir Biotechnology
VIR
+$20.6M
2
QDEL icon
QuidelOrtho
QDEL
+$9.35M
3
AVIR icon
Atea Pharmaceuticals
AVIR
+$8.57M
4
GH icon
Guardant Health
GH
+$8.32M
5
XBIT icon
XBiotech
XBIT
+$5.58M

Top Sells

Rank Stock Value
1
XBI icon
State Street SPDR S&P Biotech ETF
XBI
+$10.3M
2
CAPR icon
Capricor Therapeutics
CAPR
+$5.98M
3
DMTK
DermTech, Inc. Common Stock
DMTK
+$1.53M
4
MOTS
Motus GI Holdings, Inc. Common Stock
MOTS
+$631K
5
BDSX icon
Biodesix
BDSX
+$519K

Sector Composition

Rank Sector Weight
1 Healthcare 98.99%
2 Energy 0.06%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BHVN
1
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$295M 36.73%
2,124,055
+41,500
+2% +$5.18M
QDEL icon
2
QuidelOrtho
QDEL
$1.14B
$128M 15.93%
906,655
+69,546
+8% +$9.35M
VIR icon
3
Vir Biotechnology
VIR
$1.49B
$51.4M 6.4%
1,181,357
+475,871
+67% +$20.6M
AGEN
4
Agenus
AGEN
$275M
$49.5M 6.17%
480,832
+13,438
+3% +$1.52M
OPK icon
5
Opko Health
OPK
$1.25B
$46.8M 5.83%
12,819,073
– –
PACB icon
6
Pacific Biosciences
PACB
$432M
$36.9M 4.6%
1,444,959
+70,800
+5% +$2.1M
AWH
7
DELISTED
Aspira Women's Health Inc. Common Stock
AWH
$28.1M 3.5%
576,473
– –
BCRX icon
8
BioCryst Pharmaceuticals
BCRX
$2.48B
$27.6M 3.44%
1,920,733
– –
AXDX
9
DELISTED
Accelerate Diagnostics
AXDX
$21.9M 2.72%
375,112
-2,500
-0.7% -$163K
DMTK
10
DELISTED
DermTech, Inc. Common Stock
DMTK
$19.7M 2.45%
612,307
-43,570
-7% -$1.53M
FORA
11
DELISTED
Forian
FORA
$12.4M 1.54%
1,199,960
+331,618
+38% +$3.68M
CDAK
12
DELISTED
Codiak BioSciences, Inc. Common Stock
CDAK
$11.4M 1.42%
700,000
+21,300
+3% +$381K
AVIR icon
13
Atea Pharmaceuticals
AVIR
$361M
$10.8M 1.35%
+309,126
New +$8.57M
YMAB
14
DELISTED
Y-mAbs Therapeutics
YMAB
$9.01M 1.12%
315,642
+15,000
+5% +$473K
GH icon
15
Guardant Health
GH
$19B
$8.75M 1.09%
+70,000
New +$8.32M
ATRS
16
DELISTED
Antares Pharma, Inc.
ATRS
$6.92M 0.86%
1,900,000
– –
CFRX
17
DELISTED
ContraFect Corporation
CFRX
$6.84M 0.85%
21,111
– –
SEM
18
DELISTED
Select Medical
SEM
$5.41M 0.67%
277,802
+113,381
+69% +$2.25M
AMRN
19
Amarin Corp
AMRN
$293M
$4.28M 0.53%
41,920
-647
-2% -$63.6K
IMMP
20
Immutep
IMMP
$57M
$3.87M 0.48%
1,000,000
– –
MDGL icon
21
Madrigal Pharmaceuticals
MDGL
$12.4B
$3.07M 0.38%
+38,500
New +$3.33M
BHVN
22
CALL
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$2.17M 0.27%
+80,000
New +$9.99M
MOTS
23
DELISTED
Motus GI Holdings, Inc. Common Stock
MOTS
$2.03M 0.25%
9,825
-2,500
-20% -$631K
SLNO
24
DELISTED
Soleno Therapeutics
SLNO
$1.97M 0.25%
142,133
– –
SPY icon
25
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$783B
$1.56M 0.19%
+250,000
New +$110M
1
2

Similar funds

BIO
Blue Investment Opportunities Miami Beach, Florida $168M AUM 21.32% 1-Year Est. Return
OBWA
Oak Barrel Wealth Advisory Reston, Virginia $167M AUM
EECFX
EnCap Energy Capital Fund XII Houston, Texas $169M AUM
PW
Pandora Wealth Oakbrook Terrace, Illinois $165M AUM 18.5% 1-Year Est. Return
PWA
Principia Wealth Advisory Dallas, Texas $160M AUM 37.01% 1-Year Est. Return
AIMU
Allianz Investment Management US Minneapolis, Minnesota $160M AUM 4.75% 1-Year Est. Return
HIA
Harvest Investment Advisors Tallahassee, Florida $176M AUM
ACA
AG Campbell Advisory Baltimore, Maryland $158M AUM

Oracle Investment Management's Q3 2021 Portfolio in Review

As of Q3 2021, Oracle Investment Management held 46 positions worth $803M, up 11% from $726M the previous quarter. Its ten largest holdings account for 88% of the portfolio.

Oracle Investment Management deployed $364M of net new capital in Q3 2021, opening 17 new positions and adding to 9 existing holdings. Its largest new stake was Atea Pharmaceuticals: 309,126 shares worth $10.8M.

By sector, the portfolio is most concentrated in Healthcare at 99% of assets, up from 97% a quarter earlier, followed by Energy.

On the sell side, the largest reduction was DermTech, Inc. Common Stock, an estimated $1.53M trimmed.

  • Oracle Investment Management's largest Q3 2021 buy was Atea Pharmaceuticals: 309,126 shares worth $10.8M.
  • Oracle Investment Management added most to Vir Biotechnology in Q3 2021, an estimated $20.6M increase.
  • Oracle Investment Management's biggest Q3 2021 reduction was DermTech, Inc. Common Stock, cutting an estimated $1.53M.
  • Oracle Investment Management fully exited State Street SPDR S&P Biotech ETF in Q3 2021, selling an estimated $10.3M.
  • Oracle Investment Management's ten largest holdings make up 88% of its $803M portfolio in Q3 2021.
  • Oracle Investment Management opened 17 new positions and closed 6 in Q3 2021.
  • Oracle Investment Management's portfolio value rose 11% quarter-over-quarter to $803M.

Based on Oracle Investment Management's 13F filing for Q3 2021, filed 15 Nov 2021.